Literature DB >> 34530328

Toll-like receptor 4 deficiency facilitates α-synuclein propagation and neurodegeneration in a mouse model of prodromal Parkinson's disease.

Serena Venezia1, Walter A Kaufmann2, Gregor K Wenning1, Nadia Stefanova3.   

Abstract

The evidence linking innate immunity mechanisms and neurodegenerative diseases is growing, but the specific mechanisms are incompletely understood. Experimental data suggest that microglial TLR4 mediates the uptake and clearance of α-synuclein also termed synucleinophagy. The accumulation of misfolded α-synuclein throughout the brain is central to Parkinson's disease (PD). The distribution and progression of the pathology is often attributed to the propagation of α-synuclein. Here, we apply a classical α-synuclein propagation model of prodromal PD in wild type and TLR4 deficient mice to study the role of TLR4 in the progression of the disease. Our data suggest that TLR4 deficiency facilitates the α-synuclein seed spreading associated with reduced lysosomal activity of microglia. Three months after seed inoculation, more pronounced proteinase K-resistant α-synuclein inclusion pathology is observed in mice with TLR4 deficiency. The facilitated propagation of α-synuclein is associated with early loss of dopamine transporter (DAT) signal in the striatum and loss of dopaminergic neurons in substantia nigra pars compacta of TLR4 deficient mice. These new results support TLR4 signaling as a putative target for disease modification to slow the progression of PD and related disorders.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  CD68; DAT; Disease progression; Microglia; Parkinson's disease; Synuclein; TLR4

Mesh:

Substances:

Year:  2021        PMID: 34530328     DOI: 10.1016/j.parkreldis.2021.09.007

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  3 in total

Review 1.  Microglia in Parkinson's Disease.

Authors:  Nadia Stefanova
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 2.  Toll-like receptor-mediated neuroinflammation: relevance for cognitive dysfunctions.

Authors:  Silvia Squillace; Daniela Salvemini
Journal:  Trends Pharmacol Sci       Date:  2022-06-23       Impact factor: 17.638

3.  Serum NfL and CHI3L1 for ALS and parkinsonian disorders in the process of diagnosis.

Authors:  Shotaro Haji; Wataru Sako; Nagahisa Murakami; Yusuke Osaki; Yuishin Izumi
Journal:  J Neural Transm (Vienna)       Date:  2022-02-18       Impact factor: 3.850

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.